Add to ORKG<p>Kaplan-Meier estimations of the efficacy as determined by on-treatment analysis applying different criteria for virological failure.</p
<p>Kaplan- Meier estimates of the probability of treatment failure, fever clearance time, and the pr...
(A) Kaplan-Meier plot for the time to death. (B) Kaplan-Meier plot for the time to the occurrence of...
<p>Kaplan-Meier estimates of time to HIV-RNA >200 copies/mL or stop or intensification of PI/r monot...
<p>Kaplan-Meier plot of time to virologic failure (VL>1000 cp/mL) and of time to detectable viremia ...
<p>Kaplan Meier failure estimates of smear-positive re-treatment after treatment default, stratified...
<p>Kaplan Meier failure estimates of re-treatment for smear-positive tuberculosis by index episode s...
<p>Kaplan Meier survival analysis showing cumulative probability of failure in CQ treatment groups (...
Effect of intervention by a pharmacist based on the Kaplan-Meier estimate of survival curves.</p
<p>Kaplan-Meier estimates of mortality (a) and lost to follow-up (b) stratified by HIV status.</p
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan Meier estimates comparing intent-to-treat Group 1 to unvaccinated control Group 3 for (A) ...
<p>Kaplan Meier survival estimates among HIV infected individuals who were on ART by adherence statu...
Kaplan-Meier survival estimates for unfavorable outcomes among HIV positive patients.</p
Kaplan-Meier survival estimates for unfavorable outcomes among HIV positive patients by ART status.<...
<p>Kaplan-Meier curves comparing (A) time to viral suppression and (B) time to virological failure b...
<p>Kaplan- Meier estimates of the probability of treatment failure, fever clearance time, and the pr...
(A) Kaplan-Meier plot for the time to death. (B) Kaplan-Meier plot for the time to the occurrence of...
<p>Kaplan-Meier estimates of time to HIV-RNA >200 copies/mL or stop or intensification of PI/r monot...
<p>Kaplan-Meier plot of time to virologic failure (VL>1000 cp/mL) and of time to detectable viremia ...
<p>Kaplan Meier failure estimates of smear-positive re-treatment after treatment default, stratified...
<p>Kaplan Meier failure estimates of re-treatment for smear-positive tuberculosis by index episode s...
<p>Kaplan Meier survival analysis showing cumulative probability of failure in CQ treatment groups (...
Effect of intervention by a pharmacist based on the Kaplan-Meier estimate of survival curves.</p
<p>Kaplan-Meier estimates of mortality (a) and lost to follow-up (b) stratified by HIV status.</p
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan Meier estimates comparing intent-to-treat Group 1 to unvaccinated control Group 3 for (A) ...
<p>Kaplan Meier survival estimates among HIV infected individuals who were on ART by adherence statu...
Kaplan-Meier survival estimates for unfavorable outcomes among HIV positive patients.</p
Kaplan-Meier survival estimates for unfavorable outcomes among HIV positive patients by ART status.<...
<p>Kaplan-Meier curves comparing (A) time to viral suppression and (B) time to virological failure b...
<p>Kaplan- Meier estimates of the probability of treatment failure, fever clearance time, and the pr...
(A) Kaplan-Meier plot for the time to death. (B) Kaplan-Meier plot for the time to the occurrence of...
<p>Kaplan-Meier estimates of time to HIV-RNA >200 copies/mL or stop or intensification of PI/r monot...